Optimal Antithrombotic Management of Anticoagulated Patients With a History of Myocardial Infarction
| Autor: | Winter J. Gibbs, Susan E. Fugate, Kimi S. Vesta |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
medicine.medical_specialty
Myocardial Infarction Comorbidity Fibrinolytic Agents Internal medicine Antithrombotic medicine Humans Myocardial infarction Intensive care medicine Aspirin business.industry Anticoagulants Thrombosis General Medicine medicine.disease Clinical trial Treatment Outcome Systematic review Cardiology Cardiology and Cardiovascular Medicine business Fibrinolytic agent medicine.drug |
| Zdroj: | Cardiology in Review. 12:327-333 |
| ISSN: | 1061-5377 |
| DOI: | 10.1097/01.crd.0000128731.70567.0e |
| Popis: | A common clinical dilemma exists for optimal antithrombotic management of a patient requiring oral anticoagulation (such as venous thromboembolism) and continued secondary myocardial infarction prophylaxis. Often aspirin will be continued concomitantly with the indicated oral anticoagulation therapy; however, additional benefits and increased risks of this practice have not been established. A systematic literature review was conducted to determine the benefits and risks of antithrombotic treatment strategies. Five clinical trials met the inclusion criteria and were evaluated to answer this clinical question. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|